A descriptive study of BRCA1 testing and reactions to disclosure of test results

Cancer

Volumn 79, Issue 11, 1997, Pages 2219-2228

  Lynch, Henry T ^a   Lemon, Stephen J ^a   Durham, Carolyn ^a   Tinley, Susan T ^a   Connolly, Chris ^a   Lynch, Jane F ^a   Surdam, Jonathan ^a   Orinion, Ernest ^a   Slominski Caster, Sue ^a   Watson, Patrice ^a   Lerman, Caryn ^b   Tonin, Patricia ^d   Lenoir, Gilbert ^c   Serova, Olga ^c   Narod, Steven ^e  

^a CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b GEORGETOWN UNIVERSITY   (United States)

^c INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^d MONTREAL GENERAL HOSPITAL   (Canada)

^e WOMEN S COLLEGE HOSPITAL   (Canada)

Author keywords

BRCA1; breast carcinoma; genetic counseling; hereditary breast ovarian carcinoma

Indexed keywords

DNA;

ARTICLE; BREAST CARCINOMA; CANCER RISK; DNA DETERMINATION; FEMALE; GENE ISOLATION; GENETIC COUNSELING; GENETIC RISK; HEALTH INSURANCE; HUMAN; HUMAN CELL; HUMAN TISSUE; INFORMED CONSENT; MAJOR CLINICAL STUDY; OVARY CARCINOMA; PATIENT ATTITUDE; PRIORITY JOURNAL;

BREAST CANCER; CANCER; CLINICAL APPROACH/SOURCE; EMPIRICAL APPROACH; FAMILY MEMBERS; FEMALES; GENETICS AND REPRODUCTION; MALES; RISKS AND BENEFITS; SOCIAL DISCRIMINATION; SURVEY; UNITED STATES;

ADULT; AGED; AGED, 80 AND OVER; ATTITUDE TO HEALTH; BREAST NEOPLASMS; DISCLOSURE; EMOTIONS; FAMILY; FEMALE; GENES, BRCA1; GENETIC COUNSELING; HUMANS; INFORMED CONSENT; MALE; MIDDLE AGED; NEOPLASTIC SYNDROMES, HEREDITARY; OVARIAN NEOPLASMS; RISK ASSESSMENT; RISK FACTORS; TRUTH DISCLOSURE;

EID: 0008195461     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19970601)79:11<2219::AID-CNCR21>3.0.CO;2-Y     Document Type: Article

References (18)

1. Parker SL, Tong T, Bolden S, Wingo PA. Cancer statistics, 1996. CA Cancer J Clin 1996;65:5-27.
2. Hall JM, Lee MK, Newman B, Morrow JE, Anderson LA, Huey B, et al. Linkage of early-onset breast cancer to chromosome 17q21. Science 1990;250:1684-9.
3. Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavtigiani S, et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 1994; 266:66-71.
4. Wooster R, Bignell G, Lancaster J, Swift S, Seal S, Mangion J, et al. Identification of the breast cancer susceptibility gene BRCA2. Nature 1995;378:789-92.
5. Lerman C, Narod S, Schulman K, Hughes C, Gomez-Caminaro A, Bonney G, et al. BRCA1 testing in families with hereditary breast-ovarian cancer: a prospective study of patient decision-making and outcomes. JAMA 1996;275:1885-92.
6. Marcus JN, Watson P, Page DL, Narod SA, Lenior GN, Tonin P, et al. Hereditary breast cancer: pathobiology, prognosis, and BRCA1 and BRCA2 gene linkage. Cancer 1996;77:697-709.
7. Serova O, Montagna M, Torchard D, Narod SA, Tonin P, Sylla B, et al. A high incidence of BRCA1 mutations in 20 breast-ovarian cancer families. Am J Hum Genet 1996;58: 42-51.
8. Ford D, Easton DF, Bishop DT, Narod SA, Goldgar DE. Risks of cancer in BRCA1-mutation carriers. Lancet 1994;343: 692-5.
9. Lynch HT, Watson P, Conway TA, Lynch JF, SlominskiCaster SM, Narod SA, et al. DNA screening for breast/ovarian cancer susceptibility based on linked markers: a family study. Arch Intern Med 1993;153:1979-87.
10. Nuffield Council on Bioethics. Genetic screening: ethical issues. London: Nuffield Foundation, 1993.
11. Andrews LB, Fullerton JE, Holtzman NA, Motulsky AG. Assessing genetic risks: implications for health and social policy. Washington, DC: National Academy Press, 1994.
12. Committee of the Health Council of the Netherlands. Heredity: science and society on the possibilities and limits of genetic testing and gene therapy. Human Gene Therapy 1994;5:37-40.
13. American Society of Human Genetics. Statement of the American Society of Human Genetics on genetic testing for breast and ovarian cancer predisposition. Am J Hum Genet 1994;55:1-4.
14. Working Party of the Clinical Genetics Society. The genetic testing of children. J Med Genet 1994;31:785-97.
15. American Society for Human Genetics, American College of Medical Genetics. Points to consider: ethical, legal and psychosocial implications of genetic testing in children and adolescents. Am J Hum Genet 1995;57:1233-41.
16. Harper PS. Genetic testing, common diseases, and health service provision. Lancet 1995;346:1645-6.
17. Ministry of Health and Social Affairs. Biotechnology related to human beings [abstract]. 1993.
18. American Society of Clinical Oncology. Statement of the American Society of Clinical Oncology: genetic testing for cancer susceptibility. J Clin Oncol 1996;14:1730-6.